Dual-utility ctDNA in diffuse large B-cell lymphoma: integrated genotyping unveils minimal residual disease dynamics and subtype-specific clonal evolution
Our findings underscore the dual utility of ctDNA in enhancing prognostic stratification and elucidating subtype-specific evolutionary dynamics, supporting personalized treatment strategies in DLBCL.
Authors
- L. Wang
- Hao-Rui Shen (ORCID: https://orcid.org/0000-0003-4330-850X)
- Liu-qing Zhu
- Yifan Wu (ORCID: https://orcid.org/0000-0002-8498-8436)
- Jia-Zhu Wu
- Kaixin Du
- Si-Ying Pan
- Wei Xu
- Yue Li
- Yi-Lun Ji
- Jin-Hua Liang
- Jian-Yong Li
- Hua Yin
Institutions
- Center for Personalized Cancer Treatment (NL)
- Jiangsu Province Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- BMC Medicine
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1186/s12916-026-04756-5
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00